Y-mAbs Therapeutics Inc (NASDAQ:YMAB)
| 4.54 Delayed Data As of Jan 26 |  -0.18 / -3.81%Today’s Change | 2.94 Today|||52-Week Range 20.48 | -6.97% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2017 | Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | |||
| Operating Activities | Net Income / Starting Line | -- | -- | -14.1M | -15.9M | |
| Depreciation | -- | -- | 14.0K | 19.0K | ||
| Total Other Cash Flow | -- | -- | 491.0K | 915.0K | ||
| Funds From Operations | -- | -- | -13.6M | -15.0M | ||
| Funds From/For Other Operating Expenses | -- | -- | 22.0K | -1.5M | ||
| Net Cash Flow - Operating Activities | -- | -- | -13.6M | -13.5M | ||
| Investing | Capital Expenditures | -- | -- | -57.0K | -126.0K | |
| Net Cash Flow Investing | -- | -- | -57.0K | -126.0K | ||
| Financing | Short Term Borrowings | -- | -- | 0.00 | 0.00 | -- |
| Long Term Borrowings | -- | -- | 0.00 | 0.00 | -- | |
| Long Term Debt Reduction | -- | -- | 0.00 | 0.00 | -- | |
| Net Proceeds Stock Sale | -- | -- | -1.8M | 0.00 | ||
| Common Preferred Redeemed | -- | -- | 0.00 | 0.00 | -- | |
| Common Dividends | -- | -- | -- | -- | -- | |
| Cash Dividends Paid - Total | -- | -- | 0.00 | 0.00 | -- | |
| Other Sources - Financing | -- | -- | 0.00 | 0.00 | -- | |
| Other Uses - Financing | -- | -- | 0.00 | 0.00 | -- | |
| Net Cash Flow - Financing | -- | -- | -1.8M | 0.00 | ||
| Exchange Rate | Effect of Exchange Rate on Cash | -- | -- | 24.0K | 13.0K | |
| Net Change In Cash | 0.00 | 0.00 | -15.5M | -13.6M | ||
